Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in CRISPR THERAPEUTICS AG
CAPITAL FUND MANAGEMENT S.A. holds 95,770 shares of CRSP (CRISPR THERAPEUTICS AG), worth $4.6M as of 2026-Q1. This is a new position. CRSP represents 0.0% of CAPITAL FUND MANAGEMENT S.A.'s portfolio.
Current Value
$4.6M
Current Shares
95,770
Total Value Change
+$4.6M
Total Shares Change
+95,770
Other major holders of CRSP: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
New |
| 95,770 |
- |
| $4.6M |
| 0.0% |
| $58.06 |
37 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $36.99 | 0 |
| 2024-Q4 | Decreased | 18,097 | -63.9% | $712,297 | 0.0% | $38.65 | 0 |
| 2024-Q3 | New | 50,104 | - | $2.4M | 0.0% | $47.32 | 36 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $54.01 | 0 |